Mode
Text Size
Log in / Sign up
N/A N=34 Randomized Double-blind Treatment

Cognitive Training and Dual-task Ability

Gait Disorder

Enrolled (actual)
34
Serious AEs
0.0%
Results posted
Jun 2017
Primary outcome: Primary: Change Scores in Timed up and go With Cognitive Task — -0.89; -0.37; -0.64; -1.42 seconds — p=0.562

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Balance rehabilitation + dual-tasking (Behavioral); Standard balance rehabilitation (Behavioral); Cognitive training (speed of processing) (Behavioral); Cognitive training (general cognition) (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
All
Sponsor
VA Office of Research and Development
Primary completion
Sep 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Change Scores in Timed up and go With Cognitive Task
-0.89; -0.37; -0.64; -1.42 0.562
SECONDARY
Change Scores in Walk While Talk Test With Verbal Fluency Task
1.76; -3.83; -2.73; 3.01 0.181
SECONDARY
Change Scores in Dynamic Gait Index
2.50; 1.50; -0.38; 0.00 1.000
SECONDARY
Change Scores in Sensory Organization Test (SOT)
6.44; -1.50; -0.50; 8.60 0.05
SECONDARY
Change Scores in Preferred Gait Speed
0.07; 0.24; 0.05; 0.16 0.313
SECONDARY
Change Scores in Activities-specific Balance-related Confidence
10.70; 3.16; -0.31; -8.59 0.263

Summary

The first goal of this study is to examine the extent to which the inclusion of dual-task practice to standard balance rehabilitation results in greater benefits to dual-task ability. The second goal of this study is to examine the extent to which the addition of cognitive training following balance rehabilitation results in greater benefits to dual-task ability.

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria include:
  • > 60 years of age
  • documented balance or mobility problems
  • dual-task impairment (timed up and go with subtraction task > 15 s)

Exclusion Criteria

  • Exclusion criteria include:
  • cognitive impairment (> 2 errors on Short Portable Mental Status Questionnaire41)
  • progressive medical issues that would impact mobility (e.g., Parkinson's disease).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01895608). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search